Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO, discusses her experiences and shares resources.
Myelodysplastic Syndrome
Explore the newest developments in clinical research and treatment for myelodysplastic syndromes (MDS). Cancer Nursing Today has the latest clinical findings and perspectives on personalized risk prediction models for MDS, genetic mutations related to MDS progression, donor lymphocyte infusions, and more. From clinical trials and screening techniques to the latest treatments, learn how MDS care is evolving.
Advertisement
National Cancer Survivors Month is marked in June each year.
Valeria Santini, MD, shares her insights during the European Hematology Association 2024 Congress.
Researchers developed and piloted a novel phone-delivered positive psychology intervention called PATH.
Interprofessional team-based care is the standard for patients undergoing HSCT. But who belongs on the team?
Survival rates for myelodysplastic syndromes (MDS) varies widely – from months to decades – highlighting the need for ...
For post-transplant disease control in patients with myelodysplastic syndromes (MDS), donor lymphocyte infusion (DLI) has ...
Compared with placebo, treatment with CC-486, the oral formulation of the hypomethylating agent (HMA) azacitidine ...
Results from a randomized, proof-of-concept, phase II study demonstrated promising overall survival (OS), event-free survival ...
In a prospective multicenter study, older patients with myelodysplastic syndromes (MDS) who underwent reduced-intensity ...
Treatment with enasidenib, a small molecule inhibitor of mutant IDH2, showed promising clinical activity in patients with ...
Trending
Studying for certification tests can be intimidating. Here are some essential tips to help you do your best.
These tips are important resources for oncology nurses who are recent graduates and experienced nurses new to this specialty.
With the shift in cancer care to the ambulatory care setting, a dedicated oncology nurse educator is a key asset to nurses.
Gastroparesis occurs in 60% of patients with advanced pancreatic cancer, and is frequently overlooked in upper GI tumors.
More unique, non-traditional jobs are emerging for oncology nurses to consider outside traditional positions.
Alkaline phosphatase may serve as a discriminating marker in detecting bone lesions in patients with multiple myeloma.
Advertisement
Advertisement
Latest News
Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN, FAPO, reflects on the significance of the 50th Annual ONS Congress.
Heidi Haynes, MN, CRNP, OCN, shares what's she's looking forward to at the upcoming ONS Congress in Denver.
Visit Cancer Nursing Today at Booth #3003 in the ONS Congress Learning Hall from 11 a.m. to 3 p.m. April 10-12.
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.